-
1
-
-
4644237613
-
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
-
PMID:15322536
-
Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, et al.Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival.Nat Med 2004; 10:942-9; PMID:15322536; http://dx.doi.org/10.1038/nm1093.
-
(2004)
Nat Med
, vol.10
, pp. 942-949
-
-
Curiel, T.J.1
Coukos, G.2
Zou, L.3
Alvarez, X.4
Cheng, P.5
Mottram, P.6
-
2
-
-
77951626075
-
Regulatory T cells in cancer
-
PMID:20399961
-
Mougiakakos D, Choudhury A, Lladser A, Kiessling R, Johansson CC. Regulatory T cells in cancer.Adv Cancer Res 2010; 107:57-117; PMID:20399961; http://dx.doi.org/10.1016/S0065-230X(10)07003-X.
-
(2010)
Adv Cancer Res
, vol.107
, pp. 57-117
-
-
Mougiakakos, D.1
Choudhury, A.2
Lladser, A.3
Kiessling, R.4
Johansson, C.C.5
-
3
-
-
33846878993
-
Cyclophosphamide enhances the antitumor efficacy of adoptively transferred immune cells through the induction of cytokine expression, B-cell and T-cell homeostatic proliferation, and specific tumor infiltration
-
PMID:17255288
-
Bracci L, Moschella F, Sestili P, La Sorsa V, Valentini M, Canini I, et al.Cyclophosphamide enhances the antitumor efficacy of adoptively transferred immune cells through the induction of cytokine expression, B-cell and T-cell homeostatic proliferation, and specific tumor infiltration.Clin Cancer Res 2007; 13:644-53; PMID:17255288; http://dx.doi.org/10.1158/1078-0432.CCR-06-1209.
-
(2007)
Clin Cancer Res
, vol.13
, pp. 644-653
-
-
Bracci, L.1
Moschella, F.2
Sestili, P.3
La Sorsa, V.4
Valentini, M.5
Canini, I.6
-
4
-
-
84857789296
-
The secret ally: immunostimulation by anticancer drugs
-
PMID:22301798
-
Galluzzi L, Senovilla L, Zitvogel L, Kroemer G. The secret ally: immunostimulation by anticancer drugs.Nat Rev Drug Discov 2012; 11:215-33; PMID:22301798; http://dx.doi.org/10.1038/nrd3626.
-
(2012)
Nat Rev Drug Discov
, vol.11
, pp. 215-233
-
-
Galluzzi, L.1
Senovilla, L.2
Zitvogel, L.3
Kroemer, G.4
-
5
-
-
84872593848
-
VEGFA-VEGF Receptor pathway blockade inhibits tumor-induced regulatory T cell proliferation in colorectal cancer
-
In Press; PMID: 23108136
-
Terme M, Pernot S, Marcheteau E, Sandoval F, Benhamouda N, Colussi O, et al.VEGFA-VEGF Receptor pathway blockade inhibits tumor-induced regulatory T cell proliferation in colorectal cancer. Cancer Res 2012; In Press; PMID:23108136; http:// dx.doi.org/10.1158/0008-5472.CAN-12-2325.
-
(2012)
Cancer Res
-
-
Terme, M.1
Pernot, S.2
Marcheteau, E.3
Sandoval, F.4
Benhamouda, N.5
Colussi, O.6
-
6
-
-
67650071137
-
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
-
PMID:19478820
-
Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov 2009; 8:579-91; PMID:19478820; http://dx.doi.org/10.1038/nrd2803.
-
(2009)
Nat Rev Drug Discov
, vol.8
, pp. 579-591
-
-
Trachootham, D.1
Alexandre, J.2
Huang, P.3
-
7
-
-
84869793887
-
Arsenic Trioxide Exerts Antitumor Activity through Regulatory T Cell Depletion Mediated by Oxidative Stress in a Murine Model of Colon Cancer
-
PMID:23105136
-
Thomas-Schoemann A, Batteux F, Mongaret C, Nicco C, Chéreau C, Annereau M, et al.Arsenic Trioxide Exerts Antitumor Activity through Regulatory T Cell Depletion Mediated by Oxidative Stress in a Murine Model of Colon Cancer.J Immunol 2012; 189:5171-7; PMID:23105136; http://dx.doi.org/10.4049/jimmunol.1103094.
-
(2012)
J Immunol
, vol.189
, pp. 5171-5177
-
-
Thomas-Schoemann, A.1
Batteux, F.2
Mongaret, C.3
Nicco, C.4
Chéreau, C.5
Annereau, M.6
-
8
-
-
0035985485
-
Arsenic trioxide and breast cancer: analysis of the apoptotic, differentiative and immunomodulatory effects
-
PMID:12083632
-
Baj G, Arnulfo A, Deaglio S, Mallone R, Vigone A, De Cesaris MG, et al.Arsenic trioxide and breast cancer: analysis of the apoptotic, differentiative and immunomodulatory effects.Breast Cancer Res Treat 2002; 73:61-73; PMID:12083632; http://dx.doi.org/10.1023/A:1015272401822.
-
(2002)
Breast Cancer Res Treat
, vol.73
, pp. 61-73
-
-
Baj, G.1
Arnulfo, A.2
Deaglio, S.3
Mallone, R.4
Vigone, A.5
De Cesaris, M.G.6
-
9
-
-
33745936962
-
Opposing effects of arsenic trioxide on hepatocellular carcinomas in mice
-
PMID:16827809
-
Liu B, Pan S, Dong X, Qiao H, Jiang H, Krissansen GW, et al.Opposing effects of arsenic trioxide on hepatocellular carcinomas in mice. Cancer Sci 2006; 97:675-81; PMID:16827809; http://dx.doi.org/10.1111/j.1349-7006.2006.00230.x.
-
(2006)
Cancer Sci
, vol.97
, pp. 675-681
-
-
Liu, B.1
Pan, S.2
Dong, X.3
Qiao, H.4
Jiang, H.5
Krissansen, G.W.6
-
10
-
-
39749106934
-
NADPH oxidasederived reactive oxygen species are responsible for the high susceptibility to arsenic cytotoxicity in acute promyelocytic leukemia cells
-
PMID:17804067
-
Wang J, Li L, Cang H, Shi G, Yi J. NADPH oxidasederived reactive oxygen species are responsible for the high susceptibility to arsenic cytotoxicity in acute promyelocytic leukemia cells.Leuk Res 2008; 32:429-36; PMID:17804067; http://dx.doi.org/10.1016/j.leukres.2007.06.006.
-
(2008)
Leuk Res
, vol.32
, pp. 429-436
-
-
Wang, J.1
Li, L.2
Cang, H.3
Shi, G.4
Yi, J.5
|